SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Status:
Terminated
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: SU5416 may stop the growth of brain cancer cells by stopping blood flow to the
tumor.
PURPOSE: Phase I trial to study the safety of delivering SU5416 in children who have
recurrent or progressive brain tumors.